Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus + everolimus versus tacrolimus + MMF in kidney transplantation
2013-000796-32Phase 3Completed
- Sponsor
- Policlinico Gemelli
- Start
- Mar 2013
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in kidney transplant comparing Tacrolimus + Certican with Tacrolimus + CellCept (2 arms). Primary endpoint: Composite treatment-failure endpoint at month 12. Started Mar 2013; status: completed.
02
Drugs
everolimusmycophenolate mofetiltacrolimus
03
Conditions
kidney transplant
Beyond the preview
Go deeper on 2013-000796-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000796-32.